Bile acid-independent bile flow is differently regulated by glucagon and secretin in humans after orthotopic liver transplantation.
The present study characterizes recovery of bile secretion after orthotopic liver transplantation (OLT) in humans with special regard to hormonal regulation of bile acid-independent bile flow by glucagon and secretin. Sixty-seven patients with an uncomplicated postoperative course were studied during the first 3 weeks after OLT to determine normalization of bile flow. A group of 7 and 10 patients, respectively, underwent a biliary stimulation test by either glucagon at days 7, 14, and 21 after OLT or by secretin at days 2, 10, and 21 after OLT. Secretin tests were similarly performed in patients with acute severe rejection during the first 10 days after OLT, while glucagon tests were performed in patients with acute allograft rejection occurring 2 weeks after OLT. Furthermore, hormone effects were studied in nontransplanted patients after cholecystectomy with indwelling biliary T tube. After OLT, bile secretory function recovered and stabilized within 14 days after surgery by reconstitution of both bile acid-dependent and -independent bile flow. Two weeks after OLT, bile secretion was comparable with nontransplanted patients after cholecystectomy. Glucagon and secretin stimulated bile acid-independent bile flow in transplanted and nontransplanted patients significantly, yet secretin choleresis, unlike glucagon choleresis, had already occurred during the first days after OLT and was unaffected by acute allograft rejection. These results allow the speculation that, in humans, glucagon and secretin exert their choleretic activity by different mechanisms and/or at different anatomical sites in the liver. Assuming that secretin acts at the bile duct cells, its secretory capacity was not altered by the transplantation procedure and during moderate or severe rejection episodes, as opposed to glucagon choleresis, which most likely originates in the hepatocytes and requires an entirely reconstituted canalicular transport system after OLT.
Lenzen
R
R
Department of Medicine, Virchow Klinikum der Humboldt Universität Berlin, Germany.
Elster
J
J
Behrend
C
C
Hampel
K E
KE
Bechstein
W O
WO
Neuhaus
P
P
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001646:Bile / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D001647:Bile Acids and Salts / Q000502:physiology*; D001662:Biliary Tract Surgical Procedures; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D002763:Cholecystectomy; D005260:Female; D005934:Glucagon / Q000627:therapeutic use*; D006084:Graft Rejection / Q000503:physiopathology; D006801:Humans; D007440:Intubation; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D012633:Secretin / Q000627:therapeutic use*
D001647:Bile Acids and Salts; D002756:Cholagogues and Choleretics; D012633:Secretin; D005934:Glucagon